Literature DB >> 9311845

The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env.

J T Kimata1, J Overbaugh.   

Abstract

Previous studies suggested that the rapidly replicating, highly cytopathic, syncytium-inducing (rapid-high/SI) phenotype of simian immunodeficiency virus Mne variants that evolved in macaques inoculated with a slowly replicating, minimally cytopathic, non-syncytium-inducing (slow-low/NSI) molecular clone was not solely the result of changes in the envelope surface protein (Env SU). To define the viral determinants responsible for the change in phenotype, we molecularly cloned a rapid-high/SI variant (designated SIVMne170) derived from the peripheral blood mononuclear cells (PBMCs) of a pig-tailed macaque that was inoculated with a slow-low/NSI molecular clone, SIVMneCL8. SIVMne170 was SI and replicated with faster kinetics and was more cytopathic than the parent SIVMneCL8 in CEMx174 cells. Additionally, SIVMne170 was more cytopathic for the CD4+ T-cell population than SIVMneCL8 in macaque PBMCs. An analysis of chimeric viruses constructed between the variant SIVMne170 and the parent virus SIVMneCL8 demonstrated that there are determinants encoded within both the 5' and 3' halves of SIVMne170 that independently contribute to its rapid-high/SI phenotype. As we previously observed with other SIVMne variants, the Env SU of SIVMne170 was important for syncytium induction but was not a key determinant of cytopathicity. By contrast, the intracellular domain of the envelope transmembrane protein (Env TM) contributed to both the SI and cytopathic properties of SIVMne170. We also found that the minimal determinant within the 5' half of SIVMne170 that conferred its rapid replication kinetics and cytopathicity mapped to the capsid- and nucleocapsid-encoding regions of gag. Together, these data demonstrate that mutations selected in Gag and Env TM intracytoplasmic tail influence the replication and cytopathicity of SIVMne variants that evolve in the host.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311845      PMCID: PMC192112          DOI: 10.1128/JVI.71.10.7629-7639.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.

Authors:  A G Fisher; L Ratner; H Mitsuya; L M Marselle; M E Harper; S Broder; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

2.  Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein.

Authors:  M A Miller; T A Mietzner; M W Cloyd; W G Robey; R C Montelaro
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

3.  Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.

Authors:  M A Miller; M W Cloyd; J Liebmann; C R Rinaldo; K R Islam; S Z Wang; T A Mietzner; R C Montelaro
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

4.  Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.

Authors:  G D Ritter; M J Mulligan; S L Lydy; R W Compans
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

5.  Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.

Authors:  S K Srinivas; R V Srinivas; G M Anantharamaiah; R W Compans; J P Segrest
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

6.  Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant.

Authors:  F J Novembre; P R Johnson; M G Lewis; D C Anderson; S Klumpp; H M McClure; V M Hirsch
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain.

Authors:  C P Spies; G D Ritter; M J Mulligan; R W Compans
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

8.  Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  T Dorfman; J Luban; S P Goff; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.

Authors:  M L Marthas; R A Ramos; B L Lohman; K K Van Rompay; R E Unger; C J Miller; B Banapour; N C Pedersen; P A Luciw
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.

Authors:  R J Gorelick; D J Chabot; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  16 in total

1.  Early- and intermediate-stage variants of simian immunodeficiency virus replicate efficiently in cells lacking CCR5.

Authors:  Serene Forte; Mary-Elizabeth Harmon; Mario J Pineda; Julie Overbaugh
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 2.  On the relative fitness of early and late stage Simian immunodeficiency virus isolates.

Authors:  Dominik Wodarz
Journal:  Theor Popul Biol       Date:  2007-03-21       Impact factor: 1.570

3.  Simian immunodeficiency virus variants that differ in pathogenicity differ in fitness under rapid cell turnover conditions.

Authors:  Yegor Voronin; Julie Overbaugh; Michael Emerman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.

Authors:  Monica T Yu Kimata; Marina Cella; Julia E Biggins; Colin Rorex; Robert White; Sarah Hicks; Joelle M Wilson; Parul G Patel; Jonathan S Allan; Marco Colonna; Jason T Kimata
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype.

Authors:  N C Grassly; Z Xiang; K Ariyoshi; P Aaby; H Jensen; M Schim van der Loeff; F Dias; H Whittle; J Breuer
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

6.  Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.

Authors:  Tasha Biesinger; Robert White; Monica T Yu Kimata; Brenda K Wilson; Jonathan S Allan; Jason T Kimata
Journal:  Retrovirology       Date:  2010-10-13       Impact factor: 4.602

7.  Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne.

Authors:  J T Kimata; J J Gosink; V N KewalRamani; L M Rudensey; D R Littman; J Overbaugh
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Human immunodeficiency virus evolution towards reduced replicative fitness in vivo and the development of AIDS.

Authors:  Dominik Wodarz; David N Levy
Journal:  Proc Biol Sci       Date:  2007-10-07       Impact factor: 5.349

9.  Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens.

Authors:  Parul G Patel; Monica T Yu Kimata; Julia E Biggins; Joelle M Wilson; Jason T Kimata
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  A decrease in albumin in early SIV infection is related to viral pathogenicity.

Authors:  Susan M Graham; Sarah Holte; Jason T Kimata; Mark H Wener; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2009-04       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.